Skip to main content
210 64 61 560

Protection of a woman's future reproductive capacity

Fertility Preservation

The main reason why young women and men turn to the fertility preservation department is the various side effects that treatments for a malignant disease, including chemotherapy, radiotherapy or surgery, can cause on reproductive capacity.

Some women may also enter the fertility preservation process due to age, professional obligations, or situations that prevent them from trying to have a child.

The fertility preservation department aims to protect future reproductive capacity. It operates within the HYGEIA group and in collaboration with other major oncology units in the country.

If your referral for fertility preservation is due to a malignant disease, you should mention this as the appointment should take place as soon as possible - within 24 to 48 hours.

After taking the history, any tests deemed necessary, such as ultrasound and blood tests, will need to be performed. Information will be provided on the impact of treatment (e.g. chemotherapy) on fertility and toxicity management strategies.

Always in contact and in collaboration with the treating physician, patients are informed of all available treatment options. It is considered essential to refer to the fertility preservation department as soon as possible, before the start of any treatment.

Fertility preservation methods

  • Women: Egg and embryo freezing, ovarian tissue freezing, surgical ovarian transposition, and taking medications that suppress ovarian function, protecting against toxic drugs.

  • Men: Freezing sperm and testicular tissue

Pregnancy after treatment

According to international studies, pregnancy after cancer treatment does not negatively affect the risk of recurrence of the disease. Also, there is no documented increase in the risk of genetic disorders or cancer in the offspring, as long as a reasonable period of time has passed since the end of treatment (a delay of 2 years is usually recommended).